US FDA Put On The Clock About NAC's Use As Dietary Ingredient After Amazon Ends Sales
CRN Files Citizen Petition After Letter To Agency Prompts No Action
Executive Summary
Trade group asked FDA six months ago to reverse position it revealed in July 2020 that products containing NAC cannot be marketed as dietary supplements. After Amazon in May reported pulling NAC supplements from its site, CRN decided to ask again.
You may also be interested in...
Consumer Health Products Claiming Treatments For Moles, COVID-19 Back On US FDA Warning Radar
Product sold on Amazon among topical remedies for mole and skin tag removal back on US regulatory radar. Recent warnings show violative COVID-19 claims haven’t disappeared and supplement GMP problems remain common.
NOW Health Kept NAC Flag Flying, US FDA Hoists Banner For Comment On Rulemaking Request
NOW Health continued marketing NAC supplements after FDA warned other firms, but some retailers opted out. FDA says rulemaking for NAC as lawful dietary ingredient is likely.
NAC Safety Docket Provides US FDA Cover From Acknowledging Preclusion Error, CRN Contends
“Single legal issue” is “whether the drug preclusion provision … properly precludes NAC from being marketed in dietary supplements,” CRN says in latest comment. Other stakeholders submit comments noting numerous studies showing NAC safety and decades of use in food products.